Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing.
about
The search for novel analgesics: targets and mechanismsA review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practiceThe perception and endogenous modulation of painEffect of dexmedetomidine, an alpha2-adrenoceptor agonist, on human pupillary reflexes during general anaesthesiaContribution of alpha(2) receptor subtypes to nerve injury-induced pain and its regulation by dexmedetomidineHDU care and estimated risks of hospital mortality.The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines.Hypertensive crisis and myocardial infarction following massive clonidine overdose.Opioid and noradrenergic contributions of tapentadol in experimental neuropathic pain.Differential analgesic effects of a mu-opioid peptide, [Dmt(1)]DALDA, and morphine.A romifidine and morphine combination for epidural analgesia of the flank in cattle.DNIC-mediated analgesia produced by a supramaximal electrical or a high-dose formalin conditioning stimulus: roles of opioid and alpha2-adrenergic receptorsIntracerebroventricular Application of Dexmedetomidine Produces Antinociception and Does not Cause Neurotoxicity in RatsEsmolol modulates inhibitory neurotransmission in the substantia gelatinosa of the spinal trigeminal nucleus of the ratCaudal epidural analgesia in cattle using xylazine.Effects of dexmedetomidine on conditioned pain modulation in humans.Population pharmacokinetics of dexmedetomidine in infants after open heart surgery.Opioid attentional bias and cue-elicited craving predict future risk of prescription opioid misuse among chronic pain patients.Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough.Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.Intrathecal clonidine in the neonatal rat: dose-dependent analgesia and evaluation of spinal apoptosis and toxicity.Antinociception mediated by alpha(2)-adrenergic activation involves increasing tumor necrosis factor alpha (TNFalpha) expression and restoring TNFalpha and alpha(2)-adrenergic inhibition of norepinephrine releaseRole of serotonin and noradrenaline in stress urinary incontinence.Management of neuropathic pain following treatment for breast cancer in the absence of recurrence: a challenge for the radiation oncologist.Pain processing in the human nervous system: a selective review of nociceptive and biobehavioral pathwaysDuloxetine in diabetic neuropathy.Sustained Suppression of Hyperalgesia during Latent Sensitization by μ-, δ-, and κ-opioid receptors and α2A Adrenergic Receptors: Role of Constitutive ActivityElectroacupuncture-induced analgesia in a rat model of ankle sprain pain is mediated by spinal alpha-adrenoceptors.Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivoReview of duloxetine in the management of diabetic peripheral neuropathic pain.Inhibition of opioid release in the rat spinal cord by alpha2C adrenergic receptorsRole of signal transduction in anesthetic action. Alpha 2 adrenergic agonists.Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.Central Sensitization and Neuropathic Features of Ongoing Pain in a Rat Model of Advanced Osteoarthritis.Sex-specific modulation of spinal nociception by alpha2-adrenoceptors: differential regulation by estrogen and testosterone.Antinociception occurs with a reversal in alpha 2-adrenoceptor regulation of TNF production by peripheral monocytes/macrophages from pro- to anti-inflammatoryNeuropathic and inflammatory pain are modulated by tuberoinfundibular peptide of 39 residuesSpinal 5-HT(2) and 5-HT(3) receptors mediate low, but not high, frequency TENS-induced antihyperalgesia in rats.Analgesia induced by isolated bovine chromaffin cells implanted in rat spinal cord.Dexmedetomidine: pediatric pharmacology, clinical uses and safety.
P2860
Q24288817-5862E7E3-131F-4ACA-94FC-D88FE45C8223Q24631366-92AF41B6-78EB-43F6-935E-E0B411FAC6F9Q27011310-06E2EE95-3E0D-4503-A70A-760F95D8130CQ28346877-DCFA6374-A271-48BC-9EF0-282B6167916DQ28363081-EC78D983-644F-49D3-9106-A977B18BDBE6Q29541631-42F80909-58DC-4DFD-9E6A-F7506D0439AFQ30396983-93EBF998-AC7B-4397-8123-A393F622F527Q31394811-9A46B861-A9AD-4280-A23B-651FD90AAA66Q33599172-20812DD4-E6DE-4760-A0C3-34693A413A09Q33709927-EE4E5F61-B988-473A-88B5-FF7788ECBD3FQ33765796-0A7237F7-C988-4F2A-BF20-A1B196AE3F6DQ33772696-B0D45EB0-623A-4B5E-837E-A3AD5BD2D45FQ33974048-D379E7C2-7C00-4C47-A6D2-3D80E6AF5C3BQ34010258-1F27E5BA-9A7F-452A-B8D5-B6E5819166E3Q34081084-1FA17671-2846-4471-8645-B2A84D340A6CQ34185379-1EFC4063-1A54-4077-B5E8-3DD4B2ACD89EQ34585453-C578AB8F-1712-409F-9FAC-4E277E732907Q34614499-128A4384-8624-4A63-B2F1-C8A27695598BQ34744859-9B8DC229-A2B4-49AC-A463-8072D2F4D213Q35048705-E18C4430-7A20-451D-91A5-84D9C39213D2Q35684345-FFAAC20E-A416-469E-A0FB-D305D6482898Q35728532-EA3939C0-5029-4BF1-84EF-8A1A2E002E95Q35771624-A8D6E9DC-C737-46A6-A122-579F7E27712BQ35985235-4D063AD6-BE2D-477D-B371-333DC7DCA876Q36224081-DE0F6A9C-AD4A-4F71-B5A6-40C4E38AAF13Q36376417-3DBC7B02-054F-4EBC-9267-E76D4C100AABQ36431999-C4BA5F07-6B81-4D7A-B9E8-E50A95CC5481Q36497136-3BB289F3-FF3C-4839-B134-E13307BC5FE1Q36581162-DA4F6DA4-048C-427E-8CFD-DE35C386CDF8Q36596907-EE8510FB-1BF2-4048-A960-0AA9D88DFCB1Q36628062-507CDBDC-EAB3-4390-ACD4-C009F58820C7Q36659435-3C3BF350-B729-480B-BDA3-A4CAA652FD13Q36726650-6EA43AD8-E800-4D3D-9608-59D3ACC2948EQ36777462-4A3838FC-C31C-44F6-8852-9F02FEED5D7CQ36961149-0F2E820C-4382-46D2-9E54-ED666448BD35Q36984363-2A942D28-A85F-44CE-8DC8-93C6785BD5B5Q37088741-F4F7867C-C742-4CD5-B4A8-AEDBC67EB837Q37352808-2A4E0405-4423-4915-9615-B18C5FCD080FQ37402170-920566ED-3C8E-458B-BCDB-B83DE92D934CQ37780765-934A286F-5E70-42F5-80E0-5DB17CCFA5DA
P2860
Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing.
@en
Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing.
@nl
type
label
Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing.
@en
Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing.
@nl
prefLabel
Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing.
@en
Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing.
@nl
P1476
Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing.
@en
P2093
P304
P356
10.1016/0091-3057(85)90537-4
P407
P577
1985-05-01T00:00:00Z